Sagent Pharmaceuticals, Inc. (SGNT) - Medical Equipment - Deals and Alliances Profile

Date: September 13, 2016
Pages: 38
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SA33D29C4F0EN
Leaflet:

Download PDF Leaflet

Sagent Pharmaceuticals, Inc. (SGNT) - Medical Equipment - Deals and Alliances Profile
Summary

Sagent Pharmaceuticals, Inc. (Sagent), formerly Sagent Holding Co., is a specialty pharmaceutical company which develops and manufactures pharmaceutical products with specific concentration on injectables. It offers products in various therapeutic areas such as critical care, anti-infective, oncology and urology. The company portfolio of products include amikacin sulfate injection, USP, ampicillin and sulbactam for injection, ampicillin for injection, USP, azithromycin for injection, cefazolin for injection, USP, cefepime for injection, acetazolamide for injection, and adenosine injection, among others. The company offers its products in injection and oral dosage forms.It provides products throughout North America. Sagent is headquartered in Schaumburg, Illinois, the US.

Sagent Pharmaceuticals, Inc. (SGNT) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deal Details
Venture Financing
Sagent Pharma Secures US$40 Million In Series B Financing Round
Partnerships
Anecare Enters Into Licensing Agreement With Sagent Pharma
Equity Offering
Sagent Pharma Completes Public Offering Of Shares For US$75.3 Million
Sagent Pharma Completes IPO Of US$106 Million
Acquisition
Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer
Sagent Pharma Acquires Omega Labs for USD85.3 Million
Sagent Pharmaceuticals, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
May 03, 2016: Sagent Pharmaceuticals Reports First Quarter 2016 Financial Results
Feb 16, 2016: Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results
Aug 04, 2015: Sagent Pharmaceuticals Reports Second Quarter 2015 Financial Results
May 05, 2015: Sagent Pharmaceuticals Reports First Quarter 2015 Financial Results
Feb 19, 2015: Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Results
Corporate Communications
Mar 23, 2016: Sagent Pharmaceuticals Names Sean Brynjelsen Executive Vice President, Business Development
Feb 25, 2016: Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations
Aug 03, 2015: Sagent Pharmaceuticals Board Appoints Allan Oberman as Chief Executive Officer
Apr 16, 2015: Sagent Pharmaceuticals Appoints Michael Logerfo as President
Apr 16, 2015: Shlomo Yanai Joins Sagent Pharmaceuticals Board of Directors
Mar 26, 2015: Sagent Pharmaceuticals Announces Leadership Changes
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sagent Pharmaceuticals, Inc., Medical Equipment, Key Facts, 2015
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Deals By Market, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Sagent Pharma Secures US$40 Million In Series B Financing Round
Anecare Enters Into Licensing Agreement With Sagent Pharma
Sagent Pharma Completes Public Offering Of Shares For US$75.3 Million
Sagent Pharma Completes IPO Of US$106 Million
Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer
Sagent Pharma Acquires Omega Labs for USD85.3 Million
Sagent Pharmaceuticals, Inc., Key Competitors
Sagent Pharmaceuticals, Inc., Key Employees
Sagent Pharmaceuticals, Inc., Subsidiaries

LIST OF FIGURES

Sagent Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Sagent Pharmaceuticals, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Sagent Pharmaceuticals, Inc. (SGNT) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: